Patent · US Expired

Human monocyte colony inhibitory factor (M-CIF) polypeptides

US6811773B1 · kind B1 · utility

29Cited by

10References

85Claims

0Family size

Assignee

HUMAN GENOME SCIENCES, INC. · US

Inventors

Reiner Gentz · Silver Spring, US
Brent L. Kreider · Bedford, US
Jun Zhang · Xiamen, CN
Michael Antonaccio · Princeton, US
Donna Mendrick · Mount Airy, US
Pablo Jimenez · Ellicott City, US
Vikram Patel · Germantown, US
Craig Rosen · Laytonsville, US
Mark D. Adams · Potomac, US
Haodong Li · Gaithersburg, US
Steven Ruben · Olney, US

Key dates

Filing date	May 15, 2000
Grant date	Nov 2, 2004
Priority date	—
Expiry date	May 15, 2020

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/52
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There are disclosed therapeutic compositions and methods using a human monocyte-colony inhibitory factor (M-CIF) polypeptide (previously termed MIP1-&ggr; chemokine &bgr;1(CK&bgr;1 or ckb-1)), as well as ioslated nucleic acid molecules encoding M-CIF, and vectors, host cells and recombinant methods for producing the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.